Skip to main content

Risk of heart disease starts with the risk factors in middle-aged

January 25, 2012 (Dallas, Texas) - An analysis of 18 Postgrad confirm that the differences in risk factor burden in middle-aged translate into large differences in the lives of the risk of heart disease and blood vessels [1]."The current model when we think of prevention is to assess the risk over the next 10 years using something like the degree of risk Framingham ... and supposed to guide decision-making process," senior author Dr. Donald Lloyd-Jones (Northwestern University, said Chicago, IL) heartwire. "This approach is quite true, but this is an incomplete representation of the risk to our patients."New results of the project life risk of cardiovascular gathering, which was published in the January 26, 2012 issue of the New England Journal of Medicine, found that the risk in people in their 40s or 50S with risk factors and one or two, such as high blood pressure or high cholesterol in the blood ladders sharply over their lives. "So there is a separation between information risk in the short term that routinely calculate what we know, especially with this paper, is the long-term risks that are significantly higher."This is not necessarily news, but this is a new way to look at it that I hope to attract people's attention more," he said. "If I can tell you this, make sure you have 10-year risk may be low, but based on your personal data now, it may be at risk the lives of 50% or more of a heart attack or stroke a major before he died .... and I hope that it is a little more of a catalyst. "The study analyzed cohort studies 18 with 257 384 patients, including black and white men and women across a 50-year cohorts of birth. Important studies measuring cardiovascular risk factors at age 45.55, 65, and 75. Measuring risk factors include smoking, cholesterol levels, diabetes, and blood pressure.Account risks life events of the heart and blood vessels and shows that there is a risk factor and one even in middle age can increase significantly the risk of one in his life from cardiovascular disease compared with no risk factors, and risk rises with each risk factor further.In all parts of the meta-analysis, participants with no risk factors at the age of 55 (total cholesterol level in blood: <180 mg / dL, blood pressure <120 mm Hg systolic and diastolic 80 mm Hg, nondiabetic. Non-smokers) and was otherwise significantly better to avoid death from cardiovascular disease by the age of 80 of the participants with two or more of the major risk factors (4.7% versus 29.6% among men and 6.4% versus 20.5% among women).People with risk factor optimization has also risks a younger, fatal coronary heart disease or nonfatal MI (3.6% versus 37.5% among men, <1% versus 18.3% among women), and stroke, fatal or non-fatal (2.3% versus 8.3% between men and 5.3% versus 10.7% among women), compared with those with risk factors of two or more.A similar risk by raceThe risk of death from the age of cardiovascular disease and coronary heart disease or nonfatal MI is generally about twice that among men than among women, but risk a lifetime of blow fatal and nonfatal were similar for men and women.Also, the trends shown in a similar study from the people both white and black did not change across birth cohorts-year variety. "[We saw] similar results to striking black and white in the categories of risk factors the same, but there appeared a story that there is little accuracy, unfortunately, bad news," he said. Blacks, on average, a greater burden of cardiovascular risk factors than white people, but black people, especially men, are more likely to die at a younger age from other causes, and less likely to live out "the fate of the heart and blood vessels." "Thus, in the end of the day, we found that the risk for life for blacks and whites are similar significantly, but their access to these rates for various reasons, to some extent, and it is important to say that it is not 'Americaness African That's what created this situation. It pretty much of social and economic factors. "He said Lloyd Jones, studies of patients of Hispanic do not have enough follow-up so far to provide a strong risk of life data, but hoped that the data will be available at the end. He expects the long-term risk profile for heart and blood vessels to Asian Americans will be available shortly.Now is the time to address the risk factors"If we can get our young adults who live a healthier life styles and more of them in middle age with optimal [risk factors] levels, that would be fantastic news," said Lloyd Jones. "But if you are in middle age, and you have a risk factor or two or more, it is time to actually address this. You should get [in touch] with the doctor, they are your numbers, and understand where the danger is coming from, and almost certainly You will need to help to control these [risk factors], but no less important in a partnership lifestyle changes to control those things .... It's also a very important partnership .... You can not put horses can be completely in the barn, but you do much to mitigate these risks if you get serious about this matter. "Commenting on the study, said Dr. Aaron Epidemiology Folsum (University of Minnesota, Minneapolis) heartwire ", and the data indicate that the U.S. could eliminate coronary heart disease to a large extent if, through a pattern of life, we can help adults to avoid factors risk in the first place. cardiovascular diseases that are preventable, and we need to be more aggressive in promoting healthy lifestyles among young people, and this shows on the paper aimed at young people should be paid off in the long run, not only in less coronary artery disease , but, on the basis of induction, and also in reducing health care costs. "This study was supported by grants from the National Heart, Lung, and Blood Institute. One of the book does not have any

Comments

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such

CareFusion Issues Update on Infant Breathing Product Recall

July 5, 2012 — Medical device maker CareFusion has issued an update reminding healthcare providers of its voluntary recall of its Air Life ™ Infant Breathing Circuit, initiated back in May. The US Food and Drug Administration (FDA) has classified this action as a class 1 recall, meaning there is a reasonable probability of serious adverse health consequences or death associated with use of the defective units. The update was posted July 2 on the FDA  Website. On May 29, 2012, CareFusion sent an  Urgent Recall Notice  to customers and distributors stating that the company had identified potential risks associated with the Air Life  Infant Breathing Circuit. The action was initiated after the company received complaints of the Y adapter within the breathing circuit developing cracks during patient use. "If a crack develops in the Y adapter, this could potentially result in a leak in the closed ventilation system, leading to a loss in the intended tidal volume delivered to

FDA Approves Tapentadol ER for Diabetic Neuropathy

August 29, 2012 — The US Food and Drug Administration (FDA) has approved tapentadol extended-release (ER) ( Nucynta , Janssen Pharmaceuticals, Inc) for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults for whom a continuous opioid analgesic is required over an extended time. It is the first opioid to receive this indication, the company notes in a statement today. DPN, the most common type of neuropathy, affects an estimated 16% of the more than 25 million Americans who have diabetes. The condition is often unreported and untreated, with an estimated 2 out of 5 cases not receiving care. Tapentadol ER is already approved for the treatment of moderate to severe chronic pain in adults requiring a continuous opioid analgesic for an extended period. It is a centrally acting synthetic analgesic, although the exact mechanism of action is unknown, the release states. "Although the clinical relevance is unclear," the company n